Semaglutide thigh injection: what you need to know

What the Wegovy SmPC and NHS guidance actually say about thigh injections

The Wegovy Summary of Product Characteristics, published on the electronic Medicines Compendium (eMC), lists the anterolateral thigh (the outer, front-facing section of the upper leg) as a recommended subcutaneous injection site. The same document approves the abdomen and the upper arm. Subcutaneous means the medicine is delivered into the layer of fatty tissue just beneath the skin, not into muscle. That distinction matters for both comfort and absorption.

NHS patient information for semaglutide reinforces this: the NHS semaglutide medicines page notes that injection sites should be rotated each week to prevent localised skin changes. For people injecting their own doses, the thigh is often the easiest site to reach and to see clearly, an advantage that is easy to underestimate until you have tried the upper arm unassisted.

If you want a step-by-step walkthrough of the injection process specifically at this site, our detailed guide on how to give a semaglutide injection in the thigh covers each stage in order. For now, the clinical context is: evidence supports the thigh as fully equivalent to other approved sites, so you can read more about what to expect when using the wegovy injection in thigh before deciding on your preferred location. Pick whichever you can reach comfortably and consistently, then rotate.

Finding the right spot on your thigh, and why precision reduces discomfort

Not the whole thigh counts as suitable. The inner thigh, the back of the leg and areas close to the knee are excluded. The target zone is the outer, mid-section of the upper thigh: roughly the space a hand's width below the hip crease to a hand's width above the knee, on the front-facing outer surface.

Within that zone, avoid any skin that is bruised, tender, scarred or otherwise broken. If you have been injecting at the same spot week after week, you may notice a small patch of firmness, lipohypertrophy, caused by repeated injections into the same tissue. That is the practical reason rotation is not optional. Splitting the thigh into quadrants mentally and moving clockwise each week is a simple habit that most people find easy to maintain.

A fuller discussion of site selection, including how the thigh compares to the abdomen for first-time injectors, is on the Wegovy injection sites thigh page. Those considering the abdomen or upper arm can read across on the main semaglutide injection overview as well.

Technique points specific to the thigh site

A few technique points apply more at the thigh than elsewhere. First, the subcutaneous layer is typically thinner over the thigh than over the abdomen in leaner individuals; pinching a fold of skin before inserting the needle is good practice, and is specifically recommended in the Wegovy Patient Information Leaflet. The pen should be pressed flat against the skin and held firmly at 90 degrees until the dose is complete and the pen clicks, rushing this step is the most common reason for incomplete delivery.

Second, if you are someone who trains legs regularly, try to inject on a rest day or before exercise rather than immediately after. Post-exercise blood flow increases at the injected site and may marginally alter absorption timing, though this has not been studied in depth for Wegovy specifically and the overall effect is unlikely to be clinically significant. Still, it is a simple thing to plan around.

Finally, storage. The pen lives in the fridge, ideally not right at the back where it risks freezing. A spot in the door works well. Take it out a few minutes before you inject so it reaches room temperature; cold injections are noticeably more uncomfortable. Never use a pen that has been frozen, even if it has thawed. The Patient Information Leaflet specifies the exact room-temperature window; follow that rather than any general estimate.

For those returning to the pen after a break or moving to a new dose, the practical tips on using the Wegovy pen for a repeat dose are worth a read before you inject.

Side effects at the injection site, and when to seek advice

Localised side effects at the semaglutide thigh injection site are usually minor: a small red mark, brief stinging, or a little swelling that resolves within hours. These are common across all injection sites and are not a reason to stop treatment, though they are worth mentioning at your next clinical review if they recur regularly.

Less common, but worth knowing: nodules or lumps under the skin that do not resolve within a few weeks, skin that feels unusually hard or dimpled, or increasing pain at the site. These suggest lipohypertrophy or another localised tissue response; flag them to your prescriber rather than continuing to inject into the same area.

The broader side-effect profile of semaglutide (nausea, appetite changes and other gastrointestinal effects) is not site-specific. Those are discussed fully on the Wegovy treatment page. For anything unexpected or severe, the MHRA Yellow Card scheme lets you report suspected side effects directly. If you experience severe abdominal pain that reaches into the back, seek urgent medical attention; this is listed as a warning sign for pancreatitis in the Wegovy Patient Information Leaflet.

Semaglutide (Wegovy) is a prescription-only medicine. Clinical suitability is assessed by a prescriber at consultation, if you are considering starting treatment, you can start a free consultation with our prescribers to find out whether it is right for you.